May 5, 2027 - Live Webinar - Broadcast in Central Time

Join us for a live webinar session on imaging and best practices for counseling women with dense breast tissue. This session will review supplemental imaging options, including the pros and cons of available modalities, and explore the emerging role of AI driven risk-based imaging strategies. We’ll also discuss when breast imaging can be safely deescalated in high-risk women, helping you guide patients with clarity and evidence-based confidence.

June 24, 2026 - Live Webinar - Broadcast in Central Time

Join us for a live, case‑based webinar on how to confidently use breast cancer risk models in practice. Learn IBIS troubleshooting tips, which benign breast lesions to include, and how to explain individual vs. population‑level risk to patients. Through realistic patient‑persona cases, you'll discover how to choose the right model - and how to communicate effectively with patients identified as high risk.

October 9 - 10, 2026 - ARIA Resort & Casino - Las Vegas, Nevada

This course offers Live and Livestream options

This two-day comprehensive symposium reviews advances in bone marrow failure syndromes and hematologic malignancies. Participants will apply molecular risk stratification, optimize treatment strategies in MDS, AML, ALL, and MPNs, and integrate MRD, CHIP, and transplant considerations to improve patient-centered care

November 12 - 15, 2026 - Caesars Republic Scottsdale, a Hilton Hotel - Scottsdale, Arizona

This course offers Live (in-person) and Livestream (virtual) attendance options

This course reviews the prevention, diagnosis, and management of cardiac and vascular diseases of cancer patients throughout the continuum of their care including heart failure, myocardial ischemia, hypertension, thromboembolism, and arrhythmia. The course is directed towards the spectrum of providers who care for cancer patients to enable them to recognize the cardiovascular risk of their patients and take action to minimize this risk. This includes physicians, advance practice providers, pharmacists, and nurses in cardiology, hematology-oncology, primary care, and hospital internal medicine. The course includes lectures from experts as well as interactive case-based discussions and question and answer sessions.

November 12 - 15, 2026 - Caesars Republic Scottsdale, a Hilton Hotel - Scottsdale, Arizona

This course offers Live (in-person) and Livestream (virtual) attendance options

This course reviews the prevention, diagnosis, and management of cardiac and vascular diseases of cancer patients throughout the continuum of their care including heart failure, myocardial ischemia, hypertension, thromboembolism, and arrhythmia. The course is directed towards the spectrum of providers who care for cancer patients to enable them to recognize the cardiovascular risk of their patients and take action to minimize this risk. This includes physicians, advance practice providers, pharmacists, and nurses in cardiology, hematology-oncology, primary care, and hospital internal medicine. The course includes lectures from experts as well as interactive case-based and question and answer sessions.

November 5 - 7, 2026 - Hilton Austin - Austin, Texas

This course offers Live (in-person) and Livestream (virtual) attendance options.

This two and half day CME course offers a multidisciplinary update on the prevention, evaluation, diagnosis, management, and treatment of benign and malignant breast disease, as well as high-risk and survivorship care. Expert faculty present the latest advances in genetics, diagnostics, and treatment, with practical insights, case-based discussions, and interactive sessions for clinical practice.

November 13 - 14, 2026 - Wynn Las Vegas - Las Vegas, Nevada

This course offers Live (in-person) and Livestream (virtual) attendance options

The 2026 Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium provides a multidisciplinary overview of the importance of early diagnosis and treatment considerations, including surgery, radiation, loco-regional approaches, and systemic therapies. Nationally and internationally renowned faculty offer state-of-the-art updates on current treatment options for patients with hepato-pancreatico-biliary cancers. This timely education is delivered through case-based discussions, interactive Q&A, and didactic presentations. The target audience for this activity includes physicians and allied health professionals.